Canaccord lowered the firm’s price target on Aspen Aerogels (ASPN) to $15 from $20 and keeps a Buy rating on the shares. The firm said despite gross margin guiding for continued growth in 2025 EVs, Aspen is experiencing some inventory digestion in 1Q25 and as a result Canaccord is modeling a modest recovery off these levels for the rest of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels Reports Strong FY 2024 Earnings Growth
- Aspen Aerogels price target lowered to $18 from $21 at Craig-Hallum
- Aspen Aerogels: Strategic Growth Positioning and Financial Resilience Earns Buy Rating
- Cisco jumps after earnings beat, Trump teases reciprocal tariffs: Morning Buzz
- Aspen Aerogels falls -25.8%